Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Transgenic Caenorhabditis elegans nematodes have been engineered to express potentially amyloidic human proteins. These animals contain constructs in which the muscle-specific unc-54 promoter/enhancer of C. elegans drives the expression of the appropriate coding regions derived from human cDNA clones. Animals containing constructs expressing the 42-amino acid beta-amyloid peptide (derived from human amyloid precursor protein cDNA) produce muscle-specific deposits immunoreactive with anti-beta-amyloid polyclonal and monoclonal antibodies. A subset of these deposits also bind the amyloid-specific dye thioflavin S, indicating that these deposits have the tinctural characteristics of classic amyloid. Co-expression of beta-peptide and transthyretin, a protein implicated in preventing the formation of insoluble beta-amyloid, leads to a dramatic reduction in the number of dye-reactive deposits. These results suggest that this invertebrate model may be useful for in vivo investigation of factors that modulate amyloid formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
A new method for predicting signal sequence cleavage sites
von Heijne, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.11.4683 · Cited by 4,508
Mello, C. C., Kramer, J. M., Stinchcomb, D., & Ambros, V. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04966.x · Cited by 3,112
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Higuchi, R., Krummel, B., & Saiki, R. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.15.7351 · Cited by 2,387
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Cited by
Pandey, U. B., & Nichols, C. D. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003293 · Cited by 1,136
Finding function in novel targets: C. elegans as a model organism
Kaletta, T., & Hengartner, M. O. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2031 · Cited by 1,093
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Morimoto, R. I. (2008) · Genes & Development · doi:10.1101/gad.1657108 · Cited by 872
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Neurodegenerative disease: models, mechanisms, and a new hope
Gitler, A. D., Dhillon, P., & Shorter, J. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030205 · Cited by 739
A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease
Brehme, M., Voisine, C., Rolland, T., Wachi, S., Soper, J. H., Zhu, Y., Orton, K., Villella, A., Garza, D., Vidal, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.042 · Cited by 584
Widespread protein aggregation as an inherent part of aging in C. elegans
David, D. C., Ollikainen, N., Trinidad, J. C., Cary, M. P., Burlingame, A. L., & Kenyon, C. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000450 · Cited by 627
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
Aging as an event of proteostasis collapse
Taylor, R. C., & Dillin, A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004440 · Cited by 538
Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
Sadigh-Eteghad, S., Sabermarouf, B., Majdi, A., Talebi, M., Farhoudi, M., & Mahmoudi, J. (2015) · Medical Principles and Practice · doi:10.1159/000369101 · Cited by 537
Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J.-C., et al. (2009) · Nature Genetics · doi:10.1038/ng.300 · Cited by 535
Reduced IGF-1 signaling delays age-associated proteotoxicity in mice
Cohen, E., Paulsson, J. F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H. M., Holzenberger, M., Kelly, J. W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.014 · Cited by 488
C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging
van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M. W., Plasterk, R. H. A., & Nollen, E. A. A. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000027 · Cited by 427
Nollen, E. A. A., Garcia, S. M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R. I., & Plasterk, R. H. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307697101 · Cited by 416
Wu, Y., Wu, Z., Butko, P., Christen, Y., Lambert, M. P., Klein, W. L., Link, C. D., & Luo, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3448-06.2006 · Cited by 406
Self-citationTreusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2011) · Science · doi:10.1126/science.1213210 · Cited by 379
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W.-Y., Duennwald, M. L., Prado, V. F., & Prado, M. A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00254 · Cited by 374
Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
“elegans strain CL2006 has been described previously[27].”
MethodInfluentialNeuroprotective effects of Ginkgo biloba extract
Ahlemeyer, B., & Krieglstein, J. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3080-1 · Cited by 369
Microbial Genetic Composition Tunes Host Longevity
Han, B., Sivaramakrishnan, P., Lin, C.-C. J., Neve, I. A. A., He, J., Tay, L. W. R., Sowa, J. N., Sizovs, A., Du, G., Wang, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.036 · Cited by 353
The Mechanistic Links Between Proteasome Activity, Aging and Agerelated Diseases
Saez, I., & Vilchez, D. (2014) · Current Genomics · doi:10.2174/138920291501140306113344 · Cited by 325
Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression
Kitajka, K., Sinclair, A. J., Weisinger, R. S., Weisinger, H. S., Mathai, M., Jayasooriya, A. P., Halver, J. E., & Puskás, L. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402342101 · Cited by 313
Neurological Benefits of Omega-3 Fatty Acids
Dyall, S. C., & Michael-Titus, A. T. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8036-z · Cited by 311
Alexander, A. G., Marfil, V., & Li, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00279 · Cited by 310
“C. elegans expressing human Aβ3−42 in muscle tissue (Link, 1995; Link et al., 2001) showed an age-dependent paralysis at 20◦C (Cohen et al., 2006; McColl et al., 2009); paralysis occurred more rapidly and more severely when Aβ1−42 was produced at 25◦C (McColl et al., 2009).”
BackgroundBuckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
Ergothioneine – a diet‐derived antioxidant with therapeutic potential
Halliwell, B., Cheah, I. K., & Tang, R. M. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.13123 · Cited by 305
The insulin paradox: aging, proteotoxicity and neurodegeneration
Cohen, E., & Dillin, A. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2474 · Cited by 303
Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model
Link, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00224-5 · Cited by 301
Self-citationA natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
Perni, M., Galvagnion, C., Maltsev, A., Meisl, G., Müller, M. B. D., Challa, P. K., Kirkegaard, J. B., Flagmeier, P., Cohen, S. I. A., Cascella, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610586114 · Cited by 298
Culetto, E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.869 · Cited by 287
A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster
Finelli, A., Kelkar, A., Song, H.-J., Yang, H., & Konsolaki, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.001 · Cited by 287
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity
Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A. R., & Bartfai, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712197105 · Cited by 284
C. elegans in high-throughput drug discovery
O'Reilly, L. P., Luke, C. J., Perlmutter, D. H., Silverman, G. A., & Pak, S. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.001 · Cited by 267
Steinkraus, K. A., Smith, E. D., Davis, C., Carr, D., Pendergrass, W. R., Sutphin, G. L., Kennedy, B. K., & Kaeberlein, M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00385.x · Cited by 265
Neurotoxic effects of TDP-43 overexpression in C. elegans
Ash, P. E. A., Zhang, Y.-J., Roberts, C. M., Saldi, T., Hutter, H., Buratti, E., Petrucelli, L., & Link, C. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq230 · Cited by 248
“For a subset of these strains, completely stable transgenic strains containing chromosomally-integrated copies of the transgene were derived by g-irradiation as previously described (17).”
MethodSelf-citationSultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215
van der Goot, A. T., Zhu, W., Vázquez-Manrique, R. P., Seinstra, R. I., Dettmer, K., Michels, H., Farina, F., Krijnen, J., Melki, R., Buijsman, R. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203083109 · Cited by 194
Reis‐Rodrigues, P., Czerwieniec, G., Peters, T. W., Evani, U. S., Alavez, S., Gaman, E. A., Vantipalli, M., Mooney, S. D., Gibson, B. W., Lithgow, G. J., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00765.x · Cited by 174
“Likewise, when the A3-42 b-amyloid peptide (Ab) is expressed in C. elegans muscle, Ab aggregates form and the worms become paralyzed (Link, 1995; Drake et al., 2003; McColl et al., 2009).”
BackgroundGong, N.-J., Dibb, R., Bulk, M., van der Weerd, L., & Liu, C. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.019 · Cited by 162
“The amino acid sequence of human beta amyloid 1–42 is: H - Asp - Ala - Glu - Phe - Gly - His - Asp - Ser - Gly - Phe Glu - Val - Arg - His - Gln - Lys - Leu - Val - Phe - Phe - Ala - Glu - Asp - Val Gly - Ser - Asn - Lys - Gly - Ala - Ile - Ile - Gly - Leu - Met - Val - Gly - Gly Val - Val - Ile - Ala – OH (Link, 1995…”
Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity
van Ham, T. J., Holmberg, M. A., van der Goot, A. T., Teuling, E., Garcia-Arencibia, M., Kim, H.-E., Du, D., Thijssen, K. L., Wiersma, M., Burggraaff, R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.020 · Cited by 133
Yun, C., Stanhill, A., Yang, Y., Zhang, Y., Haynes, C. M., Xu, C.-F., Neubert, T. A., Mor, A., Philips, M. R., & Ron, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707025105 · Cited by 98
Chen, S.-Y., Huang, P.-H., & Cheng, H.-J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018128108 · Cited by 73
Teo, E., Ravi, S., Barardo, D., Kim, H.-S., Fong, S., Cazenave-Gassiot, A., Tan, T. Y., Ching, J., Kovalik, J.-P., Wenk, M. R., et al. (2019) · eLife · doi:10.7554/elife.50069 · Cited by 72
Mondal, S., Hegarty, E., Sahn, J. J., Scott, L. L., Gökçe, S. K., Martin, C., Ghorashian, N., Satarasinghe, P. N., Iyer, S., Sae-Lee, W., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00428 · Cited by 41
Heiner, F., Feistel, B., & Wink, M. (2018) · PeerJ · doi:10.7717/peerj.4683 · Cited by 40
Mukherjee, S., Russell, J. C., Carr, D. T., Burgess, J. D., Allen, M., Serie, D. J., Boehme, K. L., Kauwe, J. S. K., Naj, A. C., Fardo, D. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.016 · Cited by 39
“elegans models in which either the Ab3–42 (CL2006) or the Ab1–42 (GMC101) (both referred to subsequently as “Ab”) peptide was expressed in body wall muscle cells under the control of the unc-54 promoter [13,14].”
BackgroundThe Neuroprotective Potential of Betalains: A Focused Review
Ştefănescu, C., Voştinaru, O., Mogoşan, C., Crişan, G., & Balica, G. (2025) · Plants · doi:10.3390/plants14070994 · Cited by 10
“…betalains to specifically reduce the aggregation of beta-amyloid was investigated in a transgenic model, using the nematode Caenorhabditis elegans modified to express the human amyloid gene ( CL2006 ) and subsequently to accumulate amyloid-β 42 fragments in its muscles, leading to paralysis [67].”
Metadata
- Authors
- Link, C. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-09-26
- Volume
- 92
- Issue
- 20
- Pages
- 9368-9372
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1975595547
- Cited by
- 687
- References
- 41
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.